Gene_set	Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
GWAS_Catalog_2019	Skin pigmentation	2/13	0.017405903116529068	1.0	0	0	9.70638194612958	39.320027864368186	DUT;EIF2S2
GWAS_Catalog_2019	Blood trace element (Cu levels)	2/15	0.02294883629513588	1.0	0	0	8.412197686645637	31.75173964126585	PSMB4;COX7C
GWAS_Catalog_2019	Eating disorders (purging via substances)	2/16	0.02595651826896012	1.0	0	0	7.886435331230284	28.79599775402482	SET;NCL
GWAS_Catalog_2019	Extremely high intelligence	4/78	0.035404851130136125	1.0	0	0	3.2354606487098603	10.809371287411576	DDX27;RPL37A;LSM5;TUFM
GWAS_Catalog_2019	Eyebrow thickness	4/80	0.03831838598365988	1.0	0	0	3.1545741324921135	10.289670177258204	BTF3;MEAF6;HSPA4;ABCF2
GWAS_Catalog_2019	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	2/20	0.03943258379361895	1.0	0	0	6.309148264984227	20.39850349915553	MCM6;MRPL12
GWAS_Catalog_2019	Disease progression in age-related macular degeneration	4/97	0.06844107179728122	1.0	0	0	2.601710624735764	6.977221164104189	UQCRFS1;NDUFC2;LYAR;LSM14A
GWAS_Catalog_2019	Pulmonary artery enlargement and chronic obstructive pulmonary disease	1/5	0.07678443177463125	1.0	0	0	12.618296529968454	32.38805515009513	PSMA4
GWAS_Catalog_2019	Cannabis dependence	1/5	0.07678443177463125	1.0	0	0	12.618296529968454	32.38805515009513	UCHL5
GWAS_Catalog_2019	Very long-chain saturated fatty acid levels (fatty acid 20:0)	2/30	0.08149201388085803	1.0	0	0	4.206098843322819	10.545742387922193	USP1;KPNB1
GWAS_Catalog_2019	Blood pressure measurement (high sodium and potassium intervention)	1/6	0.0914210313838074	1.0	0	0	10.515247108307047	25.155412453460716	CDCA7
GWAS_Catalog_2019	Blood pressure measurement (low sodium intervention)	1/6	0.0914210313838074	1.0	0	0	10.515247108307047	25.155412453460716	CDCA7
GWAS_Catalog_2019	Proteinuria in chronic kidney disease	1/6	0.0914210313838074	1.0	0	0	10.515247108307047	25.155412453460716	RSL24D1
GWAS_Catalog_2019	Response to haloperidol in schizophrenia	1/6	0.0914210313838074	1.0	0	0	10.515247108307047	25.155412453460716	SNRPB2
GWAS_Catalog_2019	Educational attainment	3/71	0.10296918400724243	1.0	0	0	2.665837295063758	6.060315954803713	PSMD14;TMED2;TUFM
GWAS_Catalog_2019	Alcohol consumption in current drinkers	1/7	0.10582630556130854	1.0	0	0	9.013068949977468	20.24295768965723	ADH5
GWAS_Catalog_2019	Birth length	1/7	0.10582630556130854	1.0	0	0	9.013068949977468	20.24295768965723	SF3B4
GWAS_Catalog_2019	Response to bupropion in depression	1/7	0.10582630556130854	1.0	0	0	9.013068949977468	20.24295768965723	API5
GWAS_Catalog_2019	Antibody level in response to infection	1/8	0.12000389833556176	1.0	0	0	7.886435331230284	16.72106506780814	SRSF6
GWAS_Catalog_2019	Food allergy (maternal genetic effects)	1/8	0.12000389833556176	1.0	0	0	7.886435331230284	16.72106506780814	SNRPB2
GWAS_Catalog_2019	Insulin-like growth factors	1/8	0.12000389833556176	1.0	0	0	7.886435331230284	16.72106506780814	RPA3
GWAS_Catalog_2019	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	1/8	0.12000389833556176	1.0	0	0	7.886435331230284	16.72106506780814	MRPL12
GWAS_Catalog_2019	Cocaine dependence	1/8	0.12000389833556176	1.0	0	0	7.886435331230284	16.72106506780814	FAM53B
GWAS_Catalog_2019	Response to tocilizumab in rheumatoid arthritis	1/8	0.12000389833556176	1.0	0	0	7.886435331230284	16.72106506780814	PSMA4
GWAS_Catalog_2019	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	1/8	0.12000389833556176	1.0	0	0	7.886435331230284	16.72106506780814	RPA3
GWAS_Catalog_2019	1,5-anhydroglucitol levels	1/9	0.13395739671846146	1.0	0	0	7.010164738871364	14.092067749878078	MCM6
GWAS_Catalog_2019	Glucocorticoid-induced osteonecrosis	1/9	0.13395739671846146	1.0	0	0	7.010164738871364	14.092067749878078	CCND2
GWAS_Catalog_2019	Hippocampal subfield CA3 volume	1/9	0.13395739671846146	1.0	0	0	7.010164738871364	14.092067749878078	FAM53B
GWAS_Catalog_2019	Urinary bladder cancer	1/10	0.14769033146960184	1.0	0	0	6.309148264984227	12.067113893917599	SLBP
GWAS_Catalog_2019	Uterine fibroid size (maximum dimension)	1/10	0.14769033146960184	1.0	0	0	6.309148264984227	12.067113893917599	COX7C
GWAS_Catalog_2019	Hip minimal joint space width	1/10	0.14769033146960184	1.0	0	0	6.309148264984227	12.067113893917599	SLBP
GWAS_Catalog_2019	Hippocampal subfield CA1 volume	1/10	0.14769033146960184	1.0	0	0	6.309148264984227	12.067113893917599	FAM53B
GWAS_Catalog_2019	Brain imaging	1/10	0.14769033146960184	1.0	0	0	6.309148264984227	12.067113893917599	UBE2D1
GWAS_Catalog_2019	Coagulation factor levels	1/10	0.14769033146960184	1.0	0	0	6.309148264984227	12.067113893917599	SURF6
GWAS_Catalog_2019	Melanoma	2/43	0.14840112642315487	1.0	0	0	2.9344875651089435	5.598522068300603	PARP1;RAD23B
GWAS_Catalog_2019	Femoral neck bone mineral density	2/45	0.15948890722329245	1.0	0	0	2.8040658955485456	5.1476506312377	ARPC3;WLS
GWAS_Catalog_2019	Lead levels	2/45	0.15948890722329245	1.0	0	0	2.8040658955485456	5.1476506312377	IVNS1ABP;HSBP1
GWAS_Catalog_2019	Elevated serum carcinoembryonic antigen levels	1/11	0.1612061780406288	1.0	0	0	5.735589331803843	10.467858470489997	RPL18
GWAS_Catalog_2019	Thiopurine-induced alopecia in inflammatory bowel disease	1/11	0.1612061780406288	1.0	0	0	5.735589331803843	10.467858470489997	HELLS
GWAS_Catalog_2019	F-cell distribution	1/11	0.1612061780406288	1.0	0	0	5.735589331803843	10.467858470489997	MAD2L1
GWAS_Catalog_2019	Hippocampal subfield CA4 volume	1/11	0.1612061780406288	1.0	0	0	5.735589331803843	10.467858470489997	FAM53B
GWAS_Catalog_2019	Hippocampal tail volume	1/11	0.1612061780406288	1.0	0	0	5.735589331803843	10.467858470489997	FAM53B
GWAS_Catalog_2019	Protein C levels	1/11	0.1612061780406288	1.0	0	0	5.735589331803843	10.467858470489997	BAZ1B
GWAS_Catalog_2019	Kidney function decline traits	1/11	0.1612061780406288	1.0	0	0	5.735589331803843	10.467858470489997	RRM2
GWAS_Catalog_2019	Dentate gyrus granule cell layer volume	1/11	0.1612061780406288	1.0	0	0	5.735589331803843	10.467858470489997	FAM53B
GWAS_Catalog_2019	Depression (quantitative trait)	1/11	0.1612061780406288	1.0	0	0	5.735589331803843	10.467858470489997	EIF3F
GWAS_Catalog_2019	Urate levels in obese individuals	2/47	0.17072325964221782	1.0	0	0	2.68474394254648	4.745852468250408	CDCA7L;RPA3
GWAS_Catalog_2019	Thrombin-activatable fibrinolysis inhibitor levels	1/12	0.17450835725876654	1.0	0	0	5.257623554153524	9.178667959443157	DENR
GWAS_Catalog_2019	Ewing sarcoma	1/12	0.17450835725876654	1.0	0	0	5.257623554153524	9.178667959443157	TARDBP
GWAS_Catalog_2019	Polymyositis	1/12	0.17450835725876654	1.0	0	0	5.257623554153524	9.178667959443157	RPL38
GWAS_Catalog_2019	Ischemic stroke (small-vessel)	1/12	0.17450835725876654	1.0	0	0	5.257623554153524	9.178667959443157	PMF1
GWAS_Catalog_2019	Dentate gyrus molecular layer volume	1/12	0.17450835725876654	1.0	0	0	5.257623554153524	9.178667959443157	FAM53B
GWAS_Catalog_2019	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	1/12	0.17450835725876654	1.0	0	0	5.257623554153524	9.178667959443157	PFDN4
GWAS_Catalog_2019	Creatine kinase levels	2/48	0.17638907615311694	1.0	0	0	2.6288117770767614	4.56115421634229	PSMA6;PSMD3
GWAS_Catalog_2019	Severe influenza A (H1N1) infection	2/48	0.17638907615311694	1.0	0	0	2.6288117770767614	4.56115421634229	DRAP1;DDX18
GWAS_Catalog_2019	Multiple myeloma and monoclonal gammopathy	1/13	0.187600236285976	1.0	0	0	4.85319097306479	8.121533525312682	CDCA7L
GWAS_Catalog_2019	Airway imaging phenotypes	1/13	0.187600236285976	1.0	0	0	4.85319097306479	8.121533525312682	RPA1
GWAS_Catalog_2019	Bipolar disorder (inflammation and infection response interaction)	1/13	0.187600236285976	1.0	0	0	4.85319097306479	8.121533525312682	CLTA
GWAS_Catalog_2019	Wegener's granulomatosis	1/13	0.187600236285976	1.0	0	0	4.85319097306479	8.121533525312682	CCDC86
GWAS_Catalog_2019	Hematological parameters	1/13	0.187600236285976	1.0	0	0	4.85319097306479	8.121533525312682	BYSL
GWAS_Catalog_2019	Lipoprotein phospholipase A2 activity in cardiovascular disease	1/13	0.187600236285976	1.0	0	0	4.85319097306479	8.121533525312682	TOMM5
GWAS_Catalog_2019	Digit length ratio (right hand)	1/13	0.187600236285976	1.0	0	0	4.85319097306479	8.121533525312682	OLA1
GWAS_Catalog_2019	Dysmenorrheic pain	1/13	0.187600236285976	1.0	0	0	4.85319097306479	8.121533525312682	MAT2A
GWAS_Catalog_2019	White blood cell count (basophil)	3/95	0.1912857896478828	1.0	0	0	1.9923626099950191	3.2953412353366223	PSMD3;RPN1;FAM53B
GWAS_Catalog_2019	Response to quetiapine in schizophrenia	1/14	0.20048512941488955	1.0	0	0	4.506534474988734	7.242069411865003	VCP
GWAS_Catalog_2019	Digit length ratio (left hand)	1/14	0.20048512941488955	1.0	0	0	4.506534474988734	7.242069411865003	OLA1
GWAS_Catalog_2019	Waist-to-hip ratio adjusted for BMI (age >50)	6/250	0.20670980801964411	1.0	0	0	1.5141955835962146	2.3870375211314467	GCSH;HSP90AB1;RPL32;CBX3;TMED2;MCM5
GWAS_Catalog_2019	Esophageal cancer	1/15	0.21316629890593794	1.0	0	0	4.206098843322819	6.501294098250628	RPL6
GWAS_Catalog_2019	Urinary albumin-to-creatinine ratio	1/15	0.21316629890593794	1.0	0	0	4.206098843322819	6.501294098250628	TCEA1
GWAS_Catalog_2019	Infant length	1/15	0.21316629890593794	1.0	0	0	4.206098843322819	6.501294098250628	SF3B4
GWAS_Catalog_2019	Common carotid intima-media thickness in HIV negative individuals	1/15	0.21316629890593794	1.0	0	0	4.206098843322819	6.501294098250628	NCL
GWAS_Catalog_2019	Digit length ratio	1/15	0.21316629890593794	1.0	0	0	4.206098843322819	6.501294098250628	OLA1
GWAS_Catalog_2019	Midgestational circulating levels of PCBs	1/15	0.21316629890593794	1.0	0	0	4.206098843322819	6.501294098250628	TFAM
GWAS_Catalog_2019	Alcohol dependence	2/55	0.216740844015662	1.0	0	0	2.294235732721537	3.50800781498362	GLRX3;ADH5
GWAS_Catalog_2019	Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	9/419	0.22232176170972973	1.0	0	0	1.3551869781589032	2.03769921238782	GCSH;EEF1G;CBX5;HSP90AB1;RPL32;CBX3;TMED2;MCM5;TMEM165
GWAS_Catalog_2019	Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)	2/56	0.22257834890853231	1.0	0	0	2.253267237494367	3.3854801925034845	EEF1G;BAZ1B
GWAS_Catalog_2019	Mean corpuscular volume	8/365	0.2242141529735492	1.0	0	0	1.3828270169828445	2.0675388531618712	CCT3;PSMA3;CCND2;RPA1;SRPRB;HMGB1;TYMS;BYSL
GWAS_Catalog_2019	Multiple system atrophy (pathologically confirmed)	1/16	0.2256469557111145	1.0	0	0	3.943217665615142	5.8705979652933165	DDX18
GWAS_Catalog_2019	Electroencephalogram traits	1/16	0.2256469557111145	1.0	0	0	3.943217665615142	5.8705979652933165	MSH2
GWAS_Catalog_2019	Systolic blood pressure response to hydrochlorothiazide in hypertension	1/16	0.2256469557111145	1.0	0	0	3.943217665615142	5.8705979652933165	LSM6
GWAS_Catalog_2019	Palmitic acid (16:0) levels	1/16	0.2256469557111145	1.0	0	0	3.943217665615142	5.8705979652933165	LSM5
GWAS_Catalog_2019	Autism	1/16	0.2256469557111145	1.0	0	0	3.943217665615142	5.8705979652933165	BCAS2
GWAS_Catalog_2019	Mitral valve prolapse	1/16	0.2256469557111145	1.0	0	0	3.943217665615142	5.8705979652933165	PITPNB
GWAS_Catalog_2019	Total hippocampal volume	1/17	0.2379302604460247	1.0	0	0	3.71126368528484	5.3285495327015004	FAM53B
GWAS_Catalog_2019	QT interval (drug interaction)	1/17	0.2379302604460247	1.0	0	0	3.71126368528484	5.3285495327015004	CCND2
GWAS_Catalog_2019	Global electrical heterogeneity phenotypes	1/18	0.2500193240039598	1.0	0	0	3.505082369435682	4.858805005577408	KDM1A
GWAS_Catalog_2019	Subcutaneous adipose tissue	2/61	0.2519136482013628	1.0	0	0	2.068573201634173	2.8518775736912363	CCT3;SNRPD2
GWAS_Catalog_2019	Tonsillectomy	2/62	0.2577980815760506	1.0	0	0	2.0352091177368474	2.7588859876363094	SURF6;UQCR10
GWAS_Catalog_2019	Common carotid intima-media thickness in HIV infection	1/19	0.26191720835230675	1.0	0	0	3.320604349991698	4.448702718958836	SSB
GWAS_Catalog_2019	Coronary artery disease or ischemic stroke	1/19	0.26191720835230675	1.0	0	0	3.320604349991698	4.448702718958836	SMARCA4
GWAS_Catalog_2019	Breast cancer	5/219	0.26774547073094523	1.0	0	0	1.4404448093571294	1.8981007531148315	HSPA4;CDCA7L;CDCA7;EIF2S2;RAD23B
GWAS_Catalog_2019	White blood cell types	1/20	0.2736269274435734	1.0	0	0	3.1545741324921135	4.088295517532074	PSMD3
GWAS_Catalog_2019	Blood osmolality (transformed sodium)	1/20	0.2736269274435734	1.0	0	0	3.1545741324921135	4.088295517532074	HMGB1
GWAS_Catalog_2019	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	1/20	0.2736269274435734	1.0	0	0	3.1545741324921135	4.088295517532074	BAZ1B
GWAS_Catalog_2019	Reaction time	2/65	0.2754571303880224	1.0	0	0	1.941276389225916	2.5029328203332755	YWHAE;OLA1
GWAS_Catalog_2019	Mean corpuscular hemoglobin	7/336	0.2850530575565929	1.0	0	0	1.3144058885383807	1.6496844757822668	PSMA3;RRM1;CCND2;SRPRB;HMGB1;TYMS;BYSL
GWAS_Catalog_2019	Free thyroxine concentration	1/21	0.2851514477875881	1.0	0	0	3.0043563166591563	3.769670554629064	NUCKS1
GWAS_Catalog_2019	Gut microbiota (beta diversity)	1/21	0.2851514477875881	1.0	0	0	3.0043563166591563	3.769670554629064	AK2
GWAS_Catalog_2019	Ischemic stroke	2/67	0.28721985289189306	1.0	0	0	1.8833278402937992	2.3494652639559033	PMF1;SMARCA4
GWAS_Catalog_2019	Alcohol consumption	1/22	0.2964936893879897	1.0	0	0	2.8677946659019216	3.4864621292052207	ADH5
GWAS_Catalog_2019	Response to cognitive-behavioural therapy in anxiety disorder	1/22	0.2964936893879897	1.0	0	0	2.8677946659019216	3.4864621292052207	PSMD14
GWAS_Catalog_2019	Response to platinum-based neoadjuvant chemotherapy in cervical cancer	1/22	0.2964936893879897	1.0	0	0	2.8677946659019216	3.4864621292052207	HSBP1
GWAS_Catalog_2019	Cutaneous malignant melanoma	1/22	0.2964936893879897	1.0	0	0	2.8677946659019216	3.4864621292052207	RAD23B
GWAS_Catalog_2019	Vitiligo	3/121	0.30083396125648537	1.0	0	0	1.5642516359465026	1.8789740441111868	TRMT112;RAB5C;AHCY
GWAS_Catalog_2019	Electrocardiographic traits	1/23	0.3076565262162307	1.0	0	0	2.74310794129749	3.23349689453046	RPL21
GWAS_Catalog_2019	Non-melanoma skin cancer	1/23	0.3076565262162307	1.0	0	0	2.74310794129749	3.23349689453046	RCC2
GWAS_Catalog_2019	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	1/23	0.3076565262162307	1.0	0	0	2.74310794129749	3.23349689453046	PRIM2
GWAS_Catalog_2019	Body fat percentage	1/23	0.3076565262162307	1.0	0	0	2.74310794129749	3.23349689453046	TUFM
GWAS_Catalog_2019	IgG glycosylation	1/23	0.3076565262162307	1.0	0	0	2.74310794129749	3.23349689453046	ABCF2
GWAS_Catalog_2019	Lipid traits	1/23	0.3076565262162307	1.0	0	0	2.74310794129749	3.23349689453046	USP1
GWAS_Catalog_2019	Loneliness (MTAG)	2/71	0.31067228409718706	1.0	0	0	1.7772248633758387	2.077605493882316	ORC4;DDX27
GWAS_Catalog_2019	Relative hand skill in reading disability	1/24	0.3186427871501954	1.0	0	0	2.6288117770767614	3.0065315276756337	DAD1
GWAS_Catalog_2019	Cerebrospinal fluid clusterin levels	1/24	0.3186427871501954	1.0	0	0	2.6288117770767614	3.0065315276756337	IDH2
GWAS_Catalog_2019	Coronary artery disease or large artery stroke	1/24	0.3186427871501954	1.0	0	0	2.6288117770767614	3.0065315276756337	SMARCA4
GWAS_Catalog_2019	Stroke	2/73	0.32234207315734115	1.0	0	0	1.7285337712285551	1.95694560878532	PMF1;SMARCA4
GWAS_Catalog_2019	Urate levels	2/74	0.3281588227580268	1.0	0	0	1.7051752067524943	1.9000043858247189	BAZ1B;SF1
GWAS_Catalog_2019	Facial emotion recognition (sad faces)	1/25	0.3294552566033664	1.0	0	0	2.5236593059936907	2.802056090992216	BUD31
GWAS_Catalog_2019	Alzheimer disease and age of onset	1/25	0.3294552566033664	1.0	0	0	2.5236593059936907	2.802056090992216	DDX18
GWAS_Catalog_2019	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes	1/25	0.3294552566033664	1.0	0	0	2.5236593059936907	2.802056090992216	OLA1
GWAS_Catalog_2019	Monobrow thickness	1/25	0.3294552566033664	1.0	0	0	2.5236593059936907	2.802056090992216	BTF3
GWAS_Catalog_2019	Hemoglobin concentration	3/128	0.33118477585384043	1.0	0	0	1.4787066246056784	1.634087377985619	PTBP1;NASP;POMP
GWAS_Catalog_2019	Epithelial ovarian cancer	1/26	0.3400966752015053	1.0	0	0	2.426595486532395	2.6171447778708963	SURF6
GWAS_Catalog_2019	Palmitoleic acid (16:1n-7) levels	1/26	0.3400966752015053	1.0	0	0	2.426595486532395	2.6171447778708963	NDUFB8
GWAS_Catalog_2019	HIV-1 susceptibility	1/27	0.35056974048286826	1.0	0	0	2.336721579623788	2.4493413203101504	GLRX3
GWAS_Catalog_2019	White matter hyperintensity burden	1/27	0.35056974048286826	1.0	0	0	2.336721579623788	2.4493413203101504	PMF1
GWAS_Catalog_2019	Vitamin D levels	1/28	0.3608771076047978	1.0	0	0	2.253267237494367	2.2965700783087053	PSMA1
GWAS_Catalog_2019	Leprosy	1/28	0.3608771076047978	1.0	0	0	2.253267237494367	2.2965700783087053	COX4I1
GWAS_Catalog_2019	Coffee consumption	1/28	0.3608771076047978	1.0	0	0	2.253267237494367	2.2965700783087053	RPL6
GWAS_Catalog_2019	Male-pattern baldness	5/251	0.3668448944377906	1.0	0	0	1.2568024432239495	1.2603417889588655	PCBP1;CDCA7;FAM53B;SNRPE;TARDBP
GWAS_Catalog_2019	Quantitative traits	1/29	0.3710213899619185	1.0	0	0	2.1755683672359405	2.157066383450023	FKBP4
GWAS_Catalog_2019	Red blood cell traits	2/82	0.3741235103832082	1.0	0	0	1.538816649996153	1.5129172800170037	CCND2;KIF22
GWAS_Catalog_2019	Crohn's disease	11/613	0.3805950456379691	1.0	0	0	1.1321473232434989	1.093676211619641	TRMT112;HINT1;GPX4;UQCRC1;USP1;FAM53B;UBE2D1;CALM3;UQCR10;RPL7;TUFM
GWAS_Catalog_2019	Multiple myeloma	1/30	0.3810051598406185	1.0	0	0	2.1030494216614093	2.0293214743604158	CDCA7L
GWAS_Catalog_2019	Optic cup area	1/30	0.3810051598406185	1.0	0	0	2.1030494216614093	2.0293214743604158	KPNB1
GWAS_Catalog_2019	Pubertal anthropometrics	1/30	0.3810051598406185	1.0	0	0	2.1030494216614093	2.0293214743604158	NUCKS1
GWAS_Catalog_2019	Microalbuminuria	1/30	0.3810051598406185	1.0	0	0	2.1030494216614093	2.0293214743604158	DAD1
GWAS_Catalog_2019	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes	1/32	0.4005012498930377	1.0	0	0	1.971608832807571	1.804097775329334	RSL24D1
GWAS_Catalog_2019	Urate levels (BMI interaction)	1/33	0.410018514990012	1.0	0	0	1.911863110601281	1.7045272187958591	DDX18
GWAS_Catalog_2019	Hematological and biochemical traits	1/33	0.410018514990012	1.0	0	0	1.911863110601281	1.7045272187958591	RPS11
GWAS_Catalog_2019	Loneliness (multivariate analysis)	1/33	0.410018514990012	1.0	0	0	1.911863110601281	1.7045272187958591	MAD2L1
GWAS_Catalog_2019	Bone mineral density	2/89	0.4132707278292425	1.0	0	0	1.4177861269627476	1.2528300931519327	ABCF2;WLS
GWAS_Catalog_2019	Testicular germ cell tumor	2/90	0.4187658746366908	1.0	0	0	1.4020329477742728	1.2203901675166544	UCK2;TYMS
GWAS_Catalog_2019	Bone mineral density (spine)	1/35	0.4286035573292328	1.0	0	0	1.8026137899954933	1.5272156757017634	WLS
GWAS_Catalog_2019	Total body bone mineral density	1/36	0.43767604978190794	1.0	0	0	1.752541184717841	1.4480831661828433	PSMD13
GWAS_Catalog_2019	Gestational age at birth (maternal effect)	1/36	0.43767604978190794	1.0	0	0	1.752541184717841	1.4480831661828433	RUVBL1
GWAS_Catalog_2019	Beard thickness	1/36	0.43767604978190794	1.0	0	0	1.752541184717841	1.4480831661828433	TARDBP
GWAS_Catalog_2019	Brown vs. black hair color	1/36	0.43767604978190794	1.0	0	0	1.752541184717841	1.4480831661828433	CCND2
GWAS_Catalog_2019	Lumbar spine bone mineral density	1/36	0.43767604978190794	1.0	0	0	1.752541184717841	1.4480831661828433	WLS
GWAS_Catalog_2019	Hematocrit	3/153	0.43811495662987215	1.0	0	0	1.2370878950949464	1.0209364074753673	PTBP1;NASP;POMP
GWAS_Catalog_2019	Coronary artery disease (myocardial infarction, PTCA, CABG, angina or CIHD)	2/94	0.4404793295239362	1.0	0	0	1.3423719712732398	1.100599717749793	SNRPD2;MAD2L1
GWAS_Catalog_2019	Menopause (age at onset)	2/94	0.4404793295239362	1.0	0	0	1.3423719712732398	1.100599717749793	EIF3M;SRSF9
GWAS_Catalog_2019	HIV-1 viral setpoint	1/37	0.4466049384207956	1.0	0	0	1.7051752067524943	1.3745091343180766	MAD2L1
GWAS_Catalog_2019	Hemoglobin A1c levels	1/37	0.4466049384207956	1.0	0	0	1.7051752067524943	1.3745091343180766	SND1
GWAS_Catalog_2019	Smooth-surface caries	1/37	0.4466049384207956	1.0	0	0	1.7051752067524943	1.3745091343180766	LSM5
GWAS_Catalog_2019	Methadone dose in opioid dependence	1/37	0.4466049384207956	1.0	0	0	1.7051752067524943	1.3745091343180766	UQCRFS1
GWAS_Catalog_2019	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	1/38	0.4553924889390075	1.0	0	0	1.660302174995849	1.3059864167611546	HSBP1
GWAS_Catalog_2019	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes	1/38	0.4553924889390075	1.0	0	0	1.660302174995849	1.3059864167611546	OLA1
GWAS_Catalog_2019	Endometrial cancer (endometrioid histology)	1/39	0.4640409318233614	1.0	0	0	1.61773032435493	1.242065057850123	RUVBL1
GWAS_Catalog_2019	Serum alkaline phosphatase levels	1/39	0.4640409318233614	1.0	0	0	1.61773032435493	1.242065057850123	SURF6
GWAS_Catalog_2019	Metabolite levels (small molecules and protein measures)	1/39	0.4640409318233614	1.0	0	0	1.61773032435493	1.242065057850123	GCSH
GWAS_Catalog_2019	Hip circumference adjusted for BMI	2/99	0.4669830613831871	1.0	0	0	1.2745754070675208	0.970541112193394	SLBP;TUFM
GWAS_Catalog_2019	Blond vs. brown/black hair color	3/160	0.4670125232560653	1.0	0	0	1.1829652996845426	0.9007088390520294	CCND2;RPL34;RPL6
GWAS_Catalog_2019	Serum metabolite levels	2/100	0.472194393604549	1.0	0	0	1.2618296529968456	0.9468322111378824	BUD31;PPID
GWAS_Catalog_2019	Nickel levels	1/40	0.4725524621978995	1.0	0	0	1.5772870662460567	1.1823446484308693	TACSTD2
GWAS_Catalog_2019	Carotid plaque burden	1/40	0.4725524621978995	1.0	0	0	1.5772870662460567	1.1823446484308693	HMGB1
GWAS_Catalog_2019	Serum albumin level	1/40	0.4725524621978995	1.0	0	0	1.5772870662460567	1.1823446484308693	RPS11
GWAS_Catalog_2019	Hypertriglyceridemia	1/41	0.4809292408849708	1.0	0	0	1.538816649996153	1.126467843417903	BAZ1B
GWAS_Catalog_2019	Regular attendance at a gym or sports club	1/41	0.4809292408849708	1.0	0	0	1.538816649996153	1.126467843417903	USP1
GWAS_Catalog_2019	White blood cell count	4/227	0.486073938639082	1.0	0	0	1.111744187662419	0.8020061752229668	PSMD3;RPN1;CANX;FAM53B
GWAS_Catalog_2019	Prostate-specific antigen levels	1/43	0.4972870161437867	1.0	0	0	1.4672437825544715	1.0249987855647944	NUCKS1
GWAS_Catalog_2019	Mild influenza (H1N1) infection	1/43	0.4972870161437867	1.0	0	0	1.4672437825544715	1.0249987855647944	ABCF1
GWAS_Catalog_2019	Endometrial cancer	1/45	0.5131308728841566	1.0	0	0	1.4020329477742728	0.935470527181914	RUVBL1
GWAS_Catalog_2019	Allergic disease (asthma, hay fever or eczema)	3/172	0.5149348947252047	1.0	0	0	1.1004328369158536	0.7303735650199643	SMARCE1;PSMA6;PSMD3
GWAS_Catalog_2019	Sum eosinophil basophil counts	3/173	0.5188254918269936	1.0	0	0	1.0940719534654728	0.7179165496015996	GPX4;PSMD3;RPN1
GWAS_Catalog_2019	Erectile dysfunction	1/46	0.520865131725754	1.0	0	0	1.371553970648745	0.8946154642571605	CCT4
GWAS_Catalog_2019	Waist-to-hip ratio adjusted for BMI in active individuals	1/46	0.520865131725754	1.0	0	0	1.371553970648745	0.8946154642571605	EEF1G
GWAS_Catalog_2019	Cadmium levels	1/46	0.520865131725754	1.0	0	0	1.371553970648745	0.8946154642571605	SND1
GWAS_Catalog_2019	Waist-to-hip ratio adjusted for body mass index	2/111	0.5274281024369116	1.0	0	0	1.1367834711683291	0.7272489517369768	EEF1G;BAZ1B
GWAS_Catalog_2019	Telomere length	1/47	0.5284769075012126	1.0	0	0	1.3423719712732398	0.8561060058290406	PARP1
GWAS_Catalog_2019	Paclitaxel disposition in epithelial ovarian cancer	1/47	0.5284769075012126	1.0	0	0	1.3423719712732398	0.8561060058290406	PMF1
GWAS_Catalog_2019	Basal cell carcinoma	1/47	0.5284769075012126	1.0	0	0	1.3423719712732398	0.8561060058290406	RCC2
GWAS_Catalog_2019	Huntington's disease progression	1/47	0.5284769075012126	1.0	0	0	1.3423719712732398	0.8561060058290406	UQCRB
GWAS_Catalog_2019	Immune response to smallpox vaccine (IL-6)	1/47	0.5284769075012126	1.0	0	0	1.3423719712732398	0.8561060058290406	NDUFB6
GWAS_Catalog_2019	Atrial fibrillation	4/240	0.5296262853513944	1.0	0	0	1.0515247108307046	0.6683319065508899	YWHAE;PSMB7;NUCKS1;RPS2
GWAS_Catalog_2019	ALT levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	1/48	0.535968133783962	1.0	0	0	1.3144058885383807	0.8197694158441934	MCM2
GWAS_Catalog_2019	Alzheimer's disease	1/48	0.535968133783962	1.0	0	0	1.3144058885383807	0.8197694158441934	RFC3
GWAS_Catalog_2019	Alzheimer's disease (cognitive decline)	1/50	0.5505965210056286	1.0	0	0	1.2618296529968456	0.753000637028314	PSMA1
GWAS_Catalog_2019	Protein quantitative trait loci	1/52	0.5647651625200546	1.0	0	0	1.2132977432661975	0.6932119337491098	DUT
GWAS_Catalog_2019	Body mass index (age <50)	1/53	0.571681597834106	1.0	0	0	1.1904053330158921	0.6656426280948146	EIF3F
GWAS_Catalog_2019	Regular attendance at a pub or social club	1/53	0.571681597834106	1.0	0	0	1.1904053330158921	0.6656426280948146	ADH5
GWAS_Catalog_2019	Bone mineral density (hip)	1/54	0.5784884629882517	1.0	0	0	1.168360789811894	0.6394867105076507	ATP5A1
GWAS_Catalog_2019	Serum total protein level	1/54	0.5784884629882517	1.0	0	0	1.168360789811894	0.6394867105076507	RPS11
GWAS_Catalog_2019	Depression in smokers	1/54	0.5784884629882517	1.0	0	0	1.168360789811894	0.6394867105076507	RPL38
GWAS_Catalog_2019	Obesity	1/55	0.585187488394937	1.0	0	0	1.1471178663607686	0.6146521251670638	PITPNB
GWAS_Catalog_2019	Coronary artery calcification	1/55	0.585187488394937	1.0	0	0	1.1471178663607686	0.6146521251670638	SUCLG1
GWAS_Catalog_2019	Spherical equivalent or myopia (age of diagnosis)	3/191	0.5858170470647901	1.0	0	0	0.990965696070821	0.5299166708762706	API5;HAT1;LSM14A
GWAS_Catalog_2019	Colorectal cancer	2/124	0.5874901960467169	1.0	0	0	1.0176045588684235	0.5412595102097472	CCND2;RPS21
GWAS_Catalog_2019	Gut microbiota (functional units)	1/56	0.5917803771808989	1.0	0	0	1.1266336187471837	0.59105418817218	SUCLG1
GWAS_Catalog_2019	Hippocampal volume	1/56	0.5917803771808989	1.0	0	0	1.1266336187471837	0.59105418817218	HMGB1
GWAS_Catalog_2019	Post bronchodilator FEV1	2/126	0.5962138955607711	1.0	0	0	1.001452105553052	0.5179067559276819	PSMA4;RUVBL1
GWAS_Catalog_2019	Bipolar disorder	3/194	0.5963905198778461	1.0	0	0	0.9756414842759116	0.5042696593010589	EIF5B;NDUFAB1;RPL18
GWAS_Catalog_2019	Epstein-Barr virus copy number in lymphoblastoid cell lines	1/57	0.5982688057712996	1.0	0	0	1.1068681166638994	0.5686148852190931	GLRX3
GWAS_Catalog_2019	Blood urea nitrogen levels	1/57	0.5982688057712996	1.0	0	0	1.1068681166638994	0.5686148852190931	TFAM
GWAS_Catalog_2019	Gamma glutamyl transferase levels	1/59	0.6109388560446468	1.0	0	0	1.0693471635566487	0.5269297938919895	KDM1A
GWAS_Catalog_2019	Intelligence	1/59	0.6109388560446468	1.0	0	0	1.0693471635566487	0.5269297938919895	TUFM
GWAS_Catalog_2019	Thiazide-induced adverse metabolic effects in hypertensive patients	1/60	0.6171237001002169	1.0	0	0	1.0515247108307046	0.5075560344746267	COX4I1
GWAS_Catalog_2019	Advanced age-related macular degeneration	1/61	0.6232105294718999	1.0	0	0	1.0342866008170866	0.4890840241540511	GPX4
GWAS_Catalog_2019	Urinary albumin excretion	1/63	0.6350963135691167	1.0	0	0	1.001452105553052	0.4546378415491734	MAT2A
GWAS_Catalog_2019	Post bronchodilator FEV1/FVC ratio	3/206	0.6368993328959763	1.0	0	0	0.9188079997549846	0.4145144121425317	PSMA4;MSH2;RUVBL1
GWAS_Catalog_2019	Alzheimer's disease (late onset)	1/64	0.6408982924148348	1.0	0	0	0.9858044164037856	0.43856910965159374	BSG
GWAS_Catalog_2019	Axial length	1/64	0.6408982924148348	1.0	0	0	0.9858044164037856	0.43856910965159374	SET
GWAS_Catalog_2019	Photic sneeze reflex	1/65	0.6466083055956433	1.0	0	0	0.970638194612958	0.4232123938310781	PSMD7
GWAS_Catalog_2019	Glycated hemoglobin levels	1/66	0.652227806245282	1.0	0	0	0.9559315553006406	0.4085282305691236	CCT3
GWAS_Catalog_2019	Atopic dermatitis	1/67	0.6577582246977519	1.0	0	0	0.9416639201468996	0.3944798294160609	PFDN4
GWAS_Catalog_2019	Copper levels	1/67	0.6577582246977519	1.0	0	0	0.9416639201468996	0.3944798294160609	GLRX3
GWAS_Catalog_2019	Non-albumin protein levels	1/68	0.6632009687733711	1.0	0	0	0.92781592132121	0.3810328580498525	RPS11
GWAS_Catalog_2019	Fibrinogen levels	1/68	0.6632009687733711	1.0	0	0	0.92781592132121	0.3810328580498525	RAB5C
GWAS_Catalog_2019	Waist circumference adjusted for BMI in non-smokers	1/69	0.6685574239819518	1.0	0	0	0.91436931376583	0.3681552474564005	SF3B4
GWAS_Catalog_2019	Hip circumference	1/69	0.6685574239819518	1.0	0	0	0.91436931376583	0.3681552474564005	MCM6
GWAS_Catalog_2019	Idiopathic dilated cardiomyopathy	1/69	0.6685574239819518	1.0	0	0	0.91436931376583	0.3681552474564005	UBE2I
GWAS_Catalog_2019	Myopia	1/70	0.6738289540419349	1.0	0	0	0.9013068949977469	0.3558170145674747	HAT1
GWAS_Catalog_2019	Neutrophil percentage of granulocytes	2/148	0.6830995929163826	1.0	0	0	0.8525876033762472	0.3249335946629076	DRAP1;GPX4
GWAS_Catalog_2019	Migraine	1/74	0.6940923535163872	1.0	0	0	0.8525876033762472	0.3113225791608979	BAZ1B
GWAS_Catalog_2019	Waist-to-hip ratio adjusted for BMI	5/367	0.6941383594065673	1.0	0	0	0.8595569843302762	0.3138104790369308	EEF1G;HSP90AB1;RPL32;CBX3;TMED2
GWAS_Catalog_2019	Eosinophil percentage of granulocytes	2/152	0.6971486252658068	1.0	0	0	0.8301510874979247	0.29948252970084044	DRAP1;GPX4
GWAS_Catalog_2019	Waist-to-hip ratio adjusted for BMI (age <50)	2/153	0.7005795311998764	1.0	0	0	0.8247252633966311	0.2934763281138212	RPL32;CBX3
GWAS_Catalog_2019	General cognitive ability	4/299	0.7006136818765888	1.0	0	0	0.8440332127069201	0.30030586886713584	PSMA5;CCT7;SND1;ABCF1
GWAS_Catalog_2019	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)	1/79	0.7176657415803493	1.0	0	0	0.7986263626562313	0.2649453813889709	SF3B4
GWAS_Catalog_2019	Waist circumference adjusted for BMI (adjusted for smoking behaviour)	1/81	0.7265799145707719	1.0	0	0	0.7789071932079292	0.24878825611411545	SF3B4
GWAS_Catalog_2019	Chronic kidney disease	1/81	0.7265799145707719	1.0	0	0	0.7789071932079292	0.24878825611411545	PSMA5
GWAS_Catalog_2019	Ulcerative colitis	6/456	0.7325929178203114	1.0	0	0	0.8301510874979247	0.2583140427271232	MRPL20;HINT1;UQCRC1;FAM53B;CALM3;LSM2
GWAS_Catalog_2019	Height	7/527	0.7333863106579404	1.0	0	0	0.8380272837739959	0.2598577536975675	SF3B4;RPL5;SLBP;CCND2;RPL34;CDCA7L;TFAM
GWAS_Catalog_2019	Red blood cell count	3/246	0.7508699410891466	1.0	0	0	0.7694083249980765	0.22045304546336247	CCT3;CCND2;BYSL
GWAS_Catalog_2019	Attention deficit hyperactivity disorder	1/90	0.7633460478830882	1.0	0	0	0.7010164738871364	0.1893051627236466	NCL
GWAS_Catalog_2019	Cognitive function	1/92	0.7708220362219997	1.0	0	0	0.6857769853243725	0.1785062090817877	PSMD14
GWAS_Catalog_2019	HDL cholesterol levels	1/93	0.7744712691060865	1.0	0	0	0.6784030392456158	0.17338266399878305	ADH5
GWAS_Catalog_2019	Inflammatory skin disease	1/93	0.7744712691060865	1.0	0	0	0.6784030392456158	0.17338266399878305	SMARCA4
GWAS_Catalog_2019	Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)	1/94	0.7780625748055959	1.0	0	0	0.6711859856366199	0.16843300066897698	MCM2
GWAS_Catalog_2019	Reticulocyte fraction of red cells	2/180	0.7815917745859525	1.0	0	0	0.7010164738871364	0.1727463737288828	TAF15;HSPA4
GWAS_Catalog_2019	Mosquito bite size	1/95	0.7815968696964866	1.0	0	0	0.6641208699983397	0.16365013000554135	CDCA7
GWAS_Catalog_2019	Neurociticism	1/97	0.7884980219882105	1.0	0	0	0.6504276561839409	0.15455811971621858	RFC5
GWAS_Catalog_2019	Blood pressure	1/98	0.7918666413245811	1.0	0	0	0.6437906392841047	0.1502364536866752	RPL6
GWAS_Catalog_2019	Pursuit maintenance gain	1/99	0.7951817742330888	1.0	0	0	0.6372877035337604	0.1460564914950354	BAZ1B
GWAS_Catalog_2019	Pulse pressure	7/567	0.7981180809191804	1.0	0	0	0.7789071932079292	0.17564257615944315	SF3A3;UBE2I;CCND2;KDM1A;IDH2;MAK16;UQCR10
GWAS_Catalog_2019	Neutrophil count	2/187	0.7991964162268324	1.0	0	0	0.6747752155063345	0.1512498765893538	PSMD3;RSL24D1
GWAS_Catalog_2019	Total cholesterol levels	2/190	0.8063496135866065	1.0	0	0	0.6641208699983397	0.14294395933502638	RPL23A;THOP1
GWAS_Catalog_2019	Loneliness	1/104	0.8109843110005591	1.0	0	0	0.6066488716330988	0.12709692447581344	DDX27
GWAS_Catalog_2019	Coronary artery disease	5/433	0.819358396034081	1.0	0	0	0.7285390606217352	0.1451495245216646	SF3A3;RAB5C;PARP1;MAT2A;SMARCA4
GWAS_Catalog_2019	Mean platelet volume	3/281	0.8254068766733738	1.0	0	0	0.6735745478630848	0.12924469641509573	CBX5;PSMD13;FAM53B
GWAS_Catalog_2019	Body mass index x sex x age interaction (4df test)	1/109	0.8255711556225073	1.0	0	0	0.5788209417416723	0.11094829527850247	EIF3F
GWAS_Catalog_2019	Eosinophil counts	2/199	0.826468960745742	1.0	0	0	0.6340852527622339	0.12085215825679844	GPX4;RPN1
GWAS_Catalog_2019	Metabolite levels	1/111	0.8310866334090973	1.0	0	0	0.5683917355841647	0.10516454233895682	RPS11
GWAS_Catalog_2019	Body mass index	16/1246	0.8405165119110345	1.0	0	0	0.8101635011215701	0.1407567380655482	KHDRBS1;SET;NUCKS1;LSM5;RAD23B;HSD17B10;RPL6;TUFM;EEF1B2;PSMB4;NASP;MCM6;EIF3F;LSM14A;RPS13;KPNB1
GWAS_Catalog_2019	Cognitive performance	1/116	0.8441265529566304	1.0	0	0	0.5438920918089851	0.0921640657920628	API5
GWAS_Catalog_2019	QT interval	1/117	0.8466115329868129	1.0	0	0	0.5392434414516434	0.08979122018791537	NUCKS1
GWAS_Catalog_2019	Menarche (age at onset)	2/212	0.8522218734804999	1.0	0	0	0.5952026665079461	0.09517788891832364	NUCKS1;BYSL
GWAS_Catalog_2019	Lung adenocarcinoma	1/123	0.8607135998393025	1.0	0	0	0.5129388833320511	0.0769374812372663	CDCA7
GWAS_Catalog_2019	Cognitive decline rate in late mild cognitive impairment	1/126	0.8672721799514244	1.0	0	0	0.5007260527765259	0.07130460088209796	HP1BP3
GWAS_Catalog_2019	Psoriasis	1/127	0.8693892251150206	1.0	0	0	0.496783327951514	0.06953195756314423	PSMA6
GWAS_Catalog_2019	Resting heart rate	1/127	0.8693892251150206	1.0	0	0	0.496783327951514	0.06953195756314423	CANX
GWAS_Catalog_2019	Acne (severe)	2/223	0.8712452480513684	1.0	0	0	0.5658428937205585	0.07799112820344471	DRAP1;PCBP1
GWAS_Catalog_2019	Waist circumference adjusted for body mass index	1/128	0.8714726071334923	1.0	0	0	0.4929022082018927	0.06780897396325254	SF3B4
GWAS_Catalog_2019	Lymphocyte percentage of white cells	1/129	0.8735228595197526	1.0	0	0	0.4890812608514905	0.06613404725606717	PSMD3
GWAS_Catalog_2019	Lung cancer	2/225	0.8744529455232244	1.0	0	0	0.5608131791097091	0.07523689772901783	PSMA4;CDCA7
GWAS_Catalog_2019	Pancreatic cancer	1/130	0.8755405075587291	1.0	0	0	0.485319097306479	0.06450563475492946	KARS
GWAS_Catalog_2019	Inflammatory bowel disease	8/709	0.8779587123959695	1.0	0	0	0.7118926109996307	0.09265688898206953	MRPL20;HINT1;GPX4;UQCRC1;FAM53B;UQCR10;TUFM;LSM2
GWAS_Catalog_2019	Prostate cancer	4/399	0.8799602485000612	1.0	0	0	0.6324960666650854	0.08088267652677372	RRM2;CDCA7;RPS21;RAD23B
GWAS_Catalog_2019	Mean corpuscular hemoglobin concentration	1/133	0.8814029533053752	1.0	0	0	0.4743720499988141	0.059884905899615634	CCT3
GWAS_Catalog_2019	Squamous cell lung carcinoma	1/139	0.8923147899897983	1.0	0	0	0.4538955586319589	0.051715182843628985	CDCA7L
GWAS_Catalog_2019	HDL cholesterol	2/238	0.8935727779762375	1.0	0	0	0.5301805264692627	0.059659886547885024	ADH5;KPNB1
GWAS_Catalog_2019	Myeloid white cell count	1/140	0.8940335160656372	1.0	0	0	0.4506534474988734	0.050478600497994616	CANX
GWAS_Catalog_2019	Rosacea symptom severity	1/141	0.8957248948737533	1.0	0	0	0.4474573237577466	0.049274873089453636	LSM2
GWAS_Catalog_2019	Multiple sclerosis	2/244	0.9014546000343384	1.0	0	0	0.5171433004085433	0.05365134099346673	RPL5;KPNB1
GWAS_Catalog_2019	Hand grip strength	1/156	0.9180931814346039	1.0	0	0	0.4044325810887325	0.034561347845260035	OLA1
GWAS_Catalog_2019	Blood metabolite levels	1/158	0.9206891396087712	1.0	0	0	0.3993131813281157	0.03299637605555207	NASP
GWAS_Catalog_2019	Daytime sleep phenotypes	2/263	0.9229693517085568	1.0	0	0	0.4797831380216143	0.0384590565608695	CANX;SRSF6
GWAS_Catalog_2019	Eosinophil percentage of white cells	1/160	0.9232030703697278	1.0	0	0	0.39432176656151424	0.03150869773004705	GPX4
GWAS_Catalog_2019	Platelet count	3/366	0.931829378383658	1.0	0	0	0.5171433004085433	0.03651318790907492	PARP1;PSMD13;NHP2
GWAS_Catalog_2019	Intelligence (MTAG)	3/366	0.931829378383658	1.0	0	0	0.5171433004085433	0.03651318790907492	PSMA5;DDX27;NPM3
GWAS_Catalog_2019	Platelet distribution width	1/170	0.9346299634964208	1.0	0	0	0.371126368528484	0.02508984560916109	ATP5B
GWAS_Catalog_2019	Reticulocyte count	1/171	0.9356749281297028	1.0	0	0	0.3689560388879665	0.02453083986700609	TAF15
GWAS_Catalog_2019	Monocyte percentage of white cells	1/171	0.9356749281297028	1.0	0	0	0.3689560388879665	0.02453083986700609	RPN1
GWAS_Catalog_2019	High light scatter reticulocyte count	1/172	0.9367032398661392	1.0	0	0	0.3668109456386179	0.023985312876642163	ATP5B
GWAS_Catalog_2019	Chronic inflammatory diseases (pleiotropy)	1/177	0.9416041190036732	1.0	0	0	0.3564490545188829	0.021447663858827657	UQCR10
GWAS_Catalog_2019	LDL cholesterol	1/181	0.9452509637203091	1.0	0	0	0.3485717273471949	0.019626267205146042	SMARCA4
GWAS_Catalog_2019	Rheumatoid arthritis	1/182	0.9461266270717268	1.0	0	0	0.3466564980760565	0.01919744293429087	C1QBP
GWAS_Catalog_2019	Triglycerides	1/184	0.9478362877364304	1.0	0	0	0.34288849266218624	0.01836973114157523	BAZ1B
GWAS_Catalog_2019	Parkinson's disease	1/184	0.9478362877364304	1.0	0	0	0.34288849266218624	0.01836973114157523	NUCKS1
GWAS_Catalog_2019	Type 2 diabetes	3/397	0.9526575944623876	1.0	0	0	0.4767618336260122	0.023122821236585142	CCND2;EIF2S2;SND1
GWAS_Catalog_2019	Asthma	1/204	0.9622223776070876	1.0	0	0	0.3092719737737366	0.011909968849032813	CDCA7
GWAS_Catalog_2019	Major depressive disorder	1/212	0.9667997074307451	1.0	0	0	0.29760133325397303	0.010048191407941432	CCND2
GWAS_Catalog_2019	Monocyte count	1/224	0.9726497654839372	1.0	0	0	0.2816584046867959	0.007810729734332214	RPN1
GWAS_Catalog_2019	Obesity-related traits	7/804	0.9731588954797711	1.0	0	0	0.5493039534190248	0.014945410012576413	RFC5;RFC3;CCND2;POLD1;FAM53B;PFDN4;ADH5
GWAS_Catalog_2019	Red cell distribution width	1/230	0.975177136231302	1.0	0	0	0.27431079412974896	0.0068951162528657324	RRM1
GWAS_Catalog_2019	Plateletcrit	1/231	0.9755751178583936	1.0	0	0	0.27312330151446873	0.006753825068842626	NUDC
GWAS_Catalog_2019	Systemic lupus erythematosus	2/365	0.980576167460882	1.0	0	0	0.3457067542457111	0.00678102211582786	PRIM2;NAA10
GWAS_Catalog_2019	Autism spectrum disorder or schizophrenia	5/752	0.993092425866284	1.0	0	0	0.4194912410228875	0.0029077210971612103	PSMA4;LSM1;HSPE1;ABCF1;LSM2
GWAS_Catalog_2019	Heel bone mineral density	6/898	0.9961197505141636	1.0	0	0	0.4215466546760063	0.0016388878973263431	SF3A3;AHCY;HNRNPUL1;PSMB3;HSPA4;WLS
GWAS_Catalog_2019	Diastolic blood pressure	3/646	0.9980733642906908	1.0	0	0	0.2929945014698557	0.0005650381554568998	PSMA1;HSPA4;RPL6
GWAS_Catalog_2019	Systolic blood pressure	3/657	0.998341159632976	1.0	0	0	0.2880889618714259	0.0004782904127373263	PSMA1;OLA1;RPL6
GWAS_Catalog_2019	Intraocular pressure	1/401	0.9984514665390528	1.0	0	0	0.15733536820409544	0.00024382791886183515	RPLP2
GWAS_Catalog_2019	Schizophrenia	5/882	0.9985389663337402	1.0	0	0	0.3576614662689471	0.0005229375511172882	YWHAE;PSMA4;ANP32E;LSM1;HSPE1
GWAS_Catalog_2019	Blood protein levels	17/2091	0.9995846845220232	1.0	0	0	0.5129388833320511	0.00021307570738698895	DUT;CBX5;TAF15;GCA;RPN1;OLA1;DYNLL2;HNRNPAB;ADH5;LSM2;HINT1;RPS15A;NASP;SURF6;SRPRB;PPID;ABCF1
GWAS_Catalog_2019	Night sleep phenotypes	1/555	0.9998726187427032	1.0	0	0	0.11367834711683293	1.4481413133043979e-05	RCC1
